CFTR and cystic fibrosis: The use of recent therapies with CFTR modulators (HEMT) has led to improved life expectancy of CF patients, leading to a significant decrease in episodes of pulmonary exacerbation, with reduced hospitalization periods and improved nutritional status [124].